← Leaderboards
Yali Jia
Oregon Health & Science University
$6,803,157
Attributed
$14,196,024
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2014–25$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,196,024 · 8
By mechanism
R01$12,021,234 · 5
DP3$1,036,724 · 1
T32$831,604 · 1
R43$306,462 · 1
Top collaborators
- Steven T Bailey11 shared
- Thomas Hwang7 shared
- Kate E Keller5 shared
- Gangjun Liu4 shared
- John C Morrison3 shared
- John Peter Campbell2 shared
- Tristan Hormel1 shared
- David J Wilson1 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Steven T Bailey$2,773,465
- Thomas Hwang$1,507,875
- Gangjun Liu$589,710
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessScanningDetectionAngiographyOptical Coherence TomographyTechnologyRetinaImageBlood VesselsAreaMeasurementRetina Blood Vessel StructureAlgorithmsResolutionDiagnosisSpeedComputer SoftwareDensityCross-Sectional StudiesBlood CapillariesMorphologic ArtifactsBlood FlowResponseFluorescein Angiography
Grant awards (30)
Advancing visible-light OCT in oxygen-induced retinopathy$691,728
R01 · FY2025 · EY · contact PI
OCT Angiography for Age-related Macular Degeneration$680,119
R01 · FY2025 · EY · contact PI
OCTA Precursors of Vision-Threatening Complications of Diabetic Retinopathy$626,898
R01 · FY2025 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$177,523
T32 · FY2025 · EY
OCT Angiography for Age-related Macular Degeneration$685,663
R01 · FY2024 · EY · contact PI
OCTA Precursors of Vision-Threatening Complications of Diabetic Retinopathy$630,298
R01 · FY2024 · EY · contact PI
Advancing visible-light OCT in oxygen-induced retinopathy$623,090
R01 · FY2024 · EY · contact PI
A diagnostic platform for diabetic retinopathy based on OCT angiography and artificial intelligence$306,462
R43 · FY2024 · EY
Translational Vision Science Research at Oregon Health & Science University$163,817
T32 · FY2024 · EY
OCT Angiography for Age-related Macular Degeneration$684,259
R01 · FY2023 · EY · contact PI
OCTA Precursors of Vision-Threatening Complications of Diabetic Retinopathy$579,134
R01 · FY2023 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$175,079
T32 · FY2023 · EY
Visible-light OCT angiography, velocimetry, and oximetry for characterizing retinal vascular alterations in glaucoma$500,719
R01 · FY2022 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$156,079
T32 · FY2022 · EY
Visible-light OCT angiography, velocimetry, and oximetry for characterizing retinal vascular alterations in glaucoma$500,718
R01 · FY2021 · EY · contact PI
OCT Angiography for Neovascular Age-related Macular Degeneration$471,602
R01 · FY2021 · EY · contact PI
Translational Vision Science Research at Oregon Health & Science University$159,106
T32 · FY2021 · EY
Visible-light OCT angiography, velocimetry, and oximetry for characterizing retinal vascular alterations in glaucoma$552,591
R01 · FY2020 · EY · contact PI
OCT Angiography for Neovascular Age-related Macular Degeneration$509,060
R01 · FY2020 · EY · contact PI
Wide-field and projection-resolved optical coherence tomography angiography in diabetic retinopathy$424,803
R01 · FY2020 · EY · contact PI
OCT Angiography for Neovascular Age-related Macular Degeneration$520,500
R01 · FY2019 · EY · contact PI
Wide-field and projection-resolved optical coherence tomography angiography in diabetic retinopathy$424,803
R01 · FY2019 · EY · contact PI
OCT Angiography for Neovascular Age-related Macular Degeneration$517,882
R01 · FY2018 · EY · contact PI
Wide-field and projection-resolved optical coherence tomography angiography in diabetic retinopathy$431,936
R01 · FY2018 · EY · contact PI
Wide-field and projection-resolved optical coherence tomography angiography in diabetic retinopathy$487,587
R01 · FY2017 · EY · contact PI
OCT Angiography for Neovascular Age-related Macular Degeneration$383,380
R01 · FY2017 · EY · contact PI
OCT Angiography for Neovascular Age-related Macular Degeneration$382,300
R01 · FY2016 · EY · contact PI
OCT Angiography for Neovascular Age-related Macular Degeneration$332,024
R01 · FY2015 · EY · contact PI
Functional Optical Coherence Tomography-derived Biomarkers for Diabetic Retinopathy$1,036,724
DP3 · FY2014 · DK · contact PI
OCT Angiography for Neovascular Age-related Macular Degeneration$380,140
R01 · FY2014 · EY · contact PI